Financialsexperimental

Covista Inc. (CVSA). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.

Income Statement Balance Sheet Cash FlowQuarterly Annual

USD in thousands

Cash Flow	Q4 FY26 30 Jun 2026	Q3 FY26 31 Mar 2026	Q2 FY26 31 Dec 2025	Q1 FY26 30 Sept 2025	Q4 FY25 30 Jun 2025	Q3 FY25 31 Mar 2025	Q2 FY25 31 Dec 2024	Q1 FY25 30 Sept 2024	Q4 FY24 30 Jun 2024	Q3 FY24 31 Mar 2024	Q2 FY24 31 Dec 2023	Q1 FY24 30 Sept 2023	Q4 FY23 30 Jun 2023	Q3 FY23 31 Mar 2023	Q2 FY23 31 Dec 2022	Q1 FY23 30 Sept 2022	Q4 FY22 30 Jun 2022	Q3 FY22 31 Mar 2022	Q2 FY22 31 Dec 2021	Q1 FY22 30 Sept 2021
Net income	71,721*	41,637*	76,376*	61,832	54,212*	60,832*	75,856*	46,165	49,419*	36,821*	39,891*	10,646	22,244*	44,778*	24,144*	2,192	8,014*	349,842*	17,853*	-58,004
Loss (income) from discontinued operations	439*	16,345*	-205*	-770	250*	-38*	-4,680*	80	1,181*	620*	-2,178*	1,313	1,306*	3,961*	-527*	3,654	-5,550*	-343,985*	-15,367*	17,370
Income (loss) from continuing operations														48,739*	23,617*	5,846	2,464*	5,857*	2,486*	-40,634
Income from continuing operations	72,160*	57,982*	76,171*	61,062	54,462*	60,794*	71,176*	46,245	50,600*	37,441*	37,713*	11,959
Stock-based compensation	10,113*	9,571*	13,239*	8,293	10,409*	10,263*	11,467*	9,451	6,542*	5,900*	6,050*	7,455	3,391*	2,795*	1,968*	6,145	4,007*	4,673*	4,025*	9,906
Amortization and impairments to operating lease assets																	9,497*	10,830*	11,897*	12,524
Amortization and impairments to operating lease assets						11,238*	7,144*	6,948		7,365*	8,575*	8,765		9,316*	8,904*	19,708
Amortization of operating lease assets			7,195*	7,216
Amortization and impairments to operating lease assets	6,942*
Depreciation	11,223*	11,377*	10,954*	10,296	10,435*	10,274*	10,190*	9,803	7,570*	11,392*	10,936*	9,778	9,957*	10,157*	10,656*	10,805	11,103*	11,341*	10,580*	11,550
Amortization of acquired intangible assets	2,805*	2,805*	2,805*	2,805	2,805*	2,805*	2,805*	2,805	7,348*	8,286*	9,333*	10,677	12,303*	14,232*	16,176*	18,528	23,307*	26,817*	28,213*	18,937
Amortization and write-off of debt discount and issuance costs	660*	4,407*	1,409*	1,145	990*	2,769*	1,113*	1,113	1,113*	2,240*	1,155*	1,155	1,155*	1,155*	2,592*	4,227	8,173*	14,496*	2,127*	17,858
Provision for bad debts										12,717*	12,798*	10,226	9,608*	9,116*	8,284*	5,991	7,589*	6,975*	6,248*	6,329
Provision for bad debts			16,548*	14,883	16,383*	18,135*	14,999*	13,720
Provision for credit losses	19,912*
Deferred income taxes	3,034*	7,403*	3,502*	54,413	-1,581*	-3,522*	7,060*	16,456	15,723*	-4,307*	-2,508*	2,165	-3,369*	-1,473*	-2,874*	2,629	-3,969*	12,756*	1,521*	-10,852
Loss on disposals and impairments of property and equipment			2*	2	5*												1,227*	2,008*	-16*	282
Loss on disposals, accelerated depreciation, and impairments to property and equipment										12*	-0*	38		516*	-0*	3,483
Loss on disposals of property and equipment							7*	107
Loss on disposals and impairments of property and equipment	138*
Gain on investments	-1,159*	249*	-130*	-680	-806*	174*	171*	-613	-84*	-706*	-1,022*	447	-433*	-878*			-0*	-0*	-0*	-0
Gain on extinguishment of debt									0*	0*	0*	0	0*	0*	0*	71
Gain on sale of assets									0*				0*
Accounts and financing receivables	-12,992*	-29,546*	15,965*	-62,690				-56,803			7,687*	-50,116	5,731*	-18,300*	8,174*	-33,219	10,639*	-6,755*	42,524*	-76,289
Loss on assets held for sale									0*	0*
Accounts and financing receivables						-34,120*
Prepaid expenses and other current assets	9,319*	2,533*	26,412*	-29,841	-181*	-1,102*	14,218*	-7,389	-6,297*	-341*	3,389*	-5,532	2,290*	6,807*	1,829*	-1,602	-2,962*	33,217*	-6,115*	-23,571
Cloud computing implementation assets			-2,319*	-4,812	-10,864*	-7,888*	-6,183*	-7,888
Cloud computing implementation assets	-3,867*
Accounts payable	18,799*	-11,129*	-2,856*	1,378	10,118*	24,610*	-26,080*	-8,508	7,489*	3,017*	10,694*	-2,870	9,380*	-947*	5,647*	7,586	-9,987*	2,567*	-34,886*	26,582
Accrued payroll and benefits	3,630*	21,994*	1,229*	-24,359	3,738*	21,717*	1,190*	-21,501	3,751*	21,744*	2,809*	-8,882	-3,964*	12,426*	-12,552*	-11,593	9,953*	3,373*	-2,826*	-23,768
Accrued liabilities	471*	-2,847*	4,966*	-12,287	-5,499*	18,617*	-20,599*	-8,467	-12,326*	14,618*	11,360*	13,770	20,516*	-15,426*	4,161*	-9,010	76,223*	-82,004*	14,566*	-25,090
Deferred revenue	-15,397*	97,240*	-140,000*	109,082	-31,808*	78,109*	-118,184*	106,156	-20,313*	74,475*	-112,198*	98,658	-20,231*	55,220*	-111,580*	82,398	-22,736*	43,229*	-110,417*	154,999
Operating lease liabilities	-4,407*	-6,634*	-4,444*	-4,317	-6,953*	-7,245*	-3,362*	-7,232	-8,244*	-8,007*	-10,388*	-10,053	-21,430*	-11,835*	-13,002*	-12,921	-12,988*	-13,132*	-9,305*	-13,722
Other assets and liabilities	2,998*	-764*	-1,164*	-960	772*	-180*	-1,052*	-4,836	-7,252*	9,126*	-4,687*	-6,914	-3,133*	-758*	-6,248*	-7,406	-4,040*	1,117*	-20,506*	-4,125
Net cash provided by operating activities-continuing operations	124,382*	186,301*	29,484*	130,629	59,921*	207,856*	-23,610*	89,567	41,558*	163,740*	-7,657*	90,726	55,863*	107,545*	-49,248*	91,524	105,428*	77,365*	-59,884*	40,916
Net cash provided by operating activities-discontinued operations	-419*	-135*	260*	-80	-229*	54*	4,591*	-251	-988*	-1,119*	556*	8,959	-2,372*	458*	-732*	-130	-146,486*	-26,977*	20,114*	-52
Net cash provided by operating activities	123,963*	186,166*	29,744*	130,549	59,692*	207,910*	-19,019*	89,316	40,570*	162,621*	-7,101*	99,685	53,491*	108,003*	-49,980*	91,394	-41,058*	50,388*	-39,770*	40,864
Capital expenditures	-26,814*	-20,235*	-14,624*	-16,023	-18,990*	-10,243*	-10,680*	-10,414	3,121*	-21,686*	-15,282*	-15,046	-17,952*	-9,309*	-4,196*	-5,551	-8,805*	-7,477*	-7,448*	-7,324
Proceeds from sales of marketable securities	946*	209*	2,005*	100	0*	694*	239*	2,187	1,106*	0*	226*	400	0*				0*	0*	0*	0
Purchases of marketable securities	-1,951*	-209*	-2,004*	-100	-0*	-500*	-240*	-1,308	-191*	-0*	-198*	-300	-0*				-0*	-0*	-0*	-0
Payment for investment in business	-0*	-0*
Net cash used in investing activities	-27,819*	-20,235*	-19,623*	-16,023	-11,656*	-10,049*	-10,681*	-9,535	4,036*	-21,686*	-15,254*	-14,946	-17,952*	43,618*	-6,559*	-6,362	-10,689*	964,087*	-15,912*	-1,489,113
Payment for purchase of business, net of cash and restricted cash acquired													0*	0*	0*	0	0*	0*	6,265*	1,481,789
Proceeds from note receivable related to property sold																	0*
Proceeds from exercise of stock options	0*	0*	0*	131	19*	175*	335*	9,498	1,677*	99*	14,763*	550	1,003*	200*	181*	1,241	446*	233*	515*	7,685
Net cash (used in) provided by investing activities-continuing operations									4,036*	-21,686*	-15,254*	-14,946	-17,952*	43,618*	-4,196*	-5,551	-8,805*	2,523*
Employee taxes paid on withholding shares	-293*	-89*	-2,866*	-39,119	-1,743*	-259*	-1,481*	-10,717	-1,131*	-95*	-854*	-5,651	-378*	-106*	-622*	-3,486	-107*	-209*	-290*	-2,228
Net cash used in investing activities-discontinued operations													0*	0*	0*	0
Payment for working capital adjustment for sale of business												0	0*	0*	2,363*	811
Proceeds from stock issued under Colleague Stock Purchase Plan	485*	490*	404*	411	360*	355*	269*	298	229*	222*	169*	190	157*	162*	157*	132	135*	156*	130*	114
Proceeds from sale of business, net of cash transferred													0*				-1,884*
Repurchases of common stock for treasury	-0*	-67,504*	-164,767*	-7,595	-66,689*	-72,370*	-40,876*	-33,190	-11,503*	-89,914*	-70,072*	-90,477	-78,423*				-0*	-120,000*
Payment of debt issuance costs			-437*	-3,333									-0*	-0*	-0*	-0	-0*	-0*	-0*	-49,553
Borrowings under long-term debt obligations	163,000*	617,450*			0*	0*	0*	9,873	0*				0*	0*	0*	0	0*	0*	0*	850,000
Repayments under long-term debt obligations	-0*	-618,283*			-0*	-100,000*	-0*	-9,873	-0*			-0	-0*	-0*	-50,000*	-100,861	-392,046*	-396,667*	-0*	-291,000
Cash, cash equivalents and restricted cash at beginning of period					221,181*	195,419*			187,324*	186,077*	264,426*	275,075	317,177*	210,010*	329,995*	347,937*	789,995*	276,644*	380,315*	1,313,616
Payment of debt issuance and extinguishment costs	-421*
Net cash used in financing activities	162,771*	-75,732*	-217,666*	-49,505	-68,053*	-172,099*	-41,753*	-34,111	-10,728*	-139,688*	-55,994*	-95,388	-77,641*	-44,454*	-63,446*	-102,974	-391,572*	-548,277*	355*	515,018
Cash, cash equivalents and restricted cash at end of period						221,181	195,419			187,324	186,077	264,426	275,075	317,177	210,010	329,995	347,937	789,995	276,644	380,315
Net increase (decrease) in cash, cash equivalents and restricted cash	258,915*	90,199*	-207,545*	65,021	-20,017*	25,762*	-71,453*	45,670	33,878*	1,247*	-78,349*	-10,649	-42,102*	107,167*	-119,985*	-17,942	-443,331*	466,174*	-55,221*	-933,301
Payment on equity forward contract													0*	0*			0*
Cash, cash equivalents and restricted cash at beginning of period	148,839*	58,640*	266,185*	201,164			266,872*	221,202				275,075*	317,177*	210,010*	329,995*	347,937	791,268*	325,094*
Cash, cash equivalents and restricted cash at end of period	407,754	148,839	58,640	266,185	201,164			266,872	221,202				275,075	317,177	210,010	329,995	347,937	791,268	325,094
Accrued liability for repurchases of common stock					-4,879*	4,479*	-400*	800	-2,995*	595*	-1,200*	3,600	296*
Accrued excise tax on share repurchases			-541*	1,630	575*	754*	-2,958*	3,259	81*	899*	430*	1,928	765*
Accrued debt issuance costs				437
Payment for purchase of redeemable noncontrolling interest of subsidiary													0*				0*
Effect of exchange rate changes on cash, cash equivalents and restricted cash													0*	0*	0*	0	-12,000*	-24,000*	106,000*	-70,000
Accrued capital expenditures	10,225*	2,679*	5,011*	4,727	-3,184*	7,325*	892*	4,193	-2,368*	2,024*	-155*	9,217	-2,271*	5,265*	496*	4,713
Accrued excise tax on share repurchases	0*
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period													0	0	0	0	0	1,273,000	48,450,000
Settlement of financing liability with assets													0*
Proceeds from note receivable related to property sold — Devry University													0*